Cointime

EKR Therapeutics

company

About

EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.

  • 51 - 100

Highlights

Total Funding Amount
$68M
Funding Rounds
3
Investors
3

Details

Last Funding Type
Series C
Last Funding Money Raised
$13M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Feb 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

EKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$68M
EKR Therapeutics has raised a total of $68M in funding over 2 rounds. Their latest funding was raised on Mar 10, 2008 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 10, 2008 Series D $50M 2 — — Detail
Aug 15, 2007 Series C $13M 2 — — Detail
Jul 3, 2006 Series B $5M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
EKR Therapeutics is funded by 3 investors. Garden State Life Sciences Venture and ESP Equity Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Garden State Life Sciences Venture — Series D
ESP Equity Partners — Series D
Commerce Health Ventures — Series B
Cointime
Chủ Đề
Công Ty